World Pharma News / Search results for boehringer ingelheim

1
Vote

FDA grants fast track designation for Boehringer Ingelheim's BIBW 2992

Posted by worldpharmanews 89 days ago (http://www.worldpharmanews.com)
Category: Clinical Trials | Tags: fda boehringer ingelheim tovok

Boehringer Ingelheim's investigational cancer treatment BIBW 2992 has recently received a Fast Track Designation status by the FDA. Under this designation, Boehringer Ingelheim will conduct a pivota read more »
Discuss Add this link to... Bury

1
Vote

Novel oral anticoagulant Pradaxa® (dabigatran etexilate) approved by the European Commission

Posted by worldpharmanews 50 days ago (http://www.worldpharmanews.com)
Category: Product | Tags: pradaxa boehringer ingelheim

Boehringer Ingelheim announced that the European Commission has granted marketing authorisation of the novel, oral direct thrombin inhibitor, Pradaxa® (dabigatran etexilate) in all 27 EU member state read more »
Discuss Add this link to... Bury

1
Vote

European Commission grants full approval of HIV protease inhibitor, tipranavir (Aptivus®)

Posted by worldpharmanews 11 days ago (http://www.worldpharmanews.com)
Category: Product | Tags: boehringer ingelheim aptivus

Boehringer Ingelheim announced that the European Commission has given the full marketing authorisation to its HIV protease inhibitor (PI), Aptivus® (tipranavir). The Commission has fully approved Apt read more »
Discuss Add this link to... Bury

1
Vote

Boehringer Ingelheim announces commitment to progressing science with the Bouquet Studies

Posted by worldpharmanews 4 days ago (http://www.worldpharmanews.com)
Category: Clinical Trials | Tags: boehringer ingelheim bouquet

Data announced at the American College of Obstetricians and Gynaecologists (ACOG) annual clinical meeting suggest that up to one in ten women are suffering from a condition called hypoactive sexual d read more »
Discuss Add this link to... Bury